Sales intelligence for life sciences.
Built by people who've sold into it.
We read your team's sales calls and apply your qualification standard to every one – at a depth no manager has time for by hand. You see which open deals are genuinely qualified, which are quietly stalling, and where to focus coaching to move them.
Biotech sales has its own rules.
Grant cycles. CapEx vs OpEx distinctions that change the entire conversation. Scientific buyers who aren't the budget holders. Clinical milestones that move. Procurement gates that appear at month six.
Horizontal conversation-intelligence tools score whether "budget"was mentioned. That's the wrong question.
We've built a biotech-specific sales qualification methodology — drawn from years of selling into life sciences — and turned it into a qualification enginethat reads your team's calls and shows you what generic tools miss.
You send us transcripts. We deliver a report you can act on.
The methodology distinguishes grant from CapEx from other budgets. It tells a principal investigator apart from a core-facility manager — and their decision-making influence. It flags risks and urgency drivers generic tools miss — demo qualification depth, grant deadlines, risks not addressed.
Here's what shows up in your report.
You already sit on the most valuable sales data you own.
Weak qualification rarely shows up as a lost deal. It shows up as a longer cycle and a forecast you can't trust – and by then the call that caused it is months behind you.
Every call your team has run is sitting in your recorder. You've paid for it once. Almost nobody is extracting real insight from it.
- 01No installation, no integration, no IT conversationYou send transcripts, we deliver the report.
- 02No change to how your team worksNothing to learn, nothing to adopt, nothing to resist.
- 03Fast to valueWeeks, not quarters.
- 04Low commitmentA fixed-scope pilot, not a platform contract. You get the insight first. If it's useful, we talk about what comes next.
How we handle your data
Transcripts are anonymised before processing on request. Processed on servers of your choice where required. GDPR-compliant, UK-based, DPA available.
Sales managers and commercial leaders at companies selling into biotech or pharma.
- You sell reagents, instruments, CROs/CDMO services, diagnostics, or anything adjacent
- Your team records sales calls (Gong, Zoom, Teams, any recorder)
- You want a quick, sharp, tailored diagnosis of how your team is performing — and where coaching or process changes would move deals
- You suspect your team is missing qualification signals specific to scientific buyers
- Even if only your inbound or inside-sales calls are recorded – that's enough to start.
- Your calls aren't recorded or transcribed
- You want live call coaching (not what we do — yet)
New in the role?
Just stepped into a commercial leadership role? Get an honest baseline of the team you've inherited before you change anything. No politics, no self-audit – a clear read of where qualification is strong and where deals are quietly at risk, in your first 90 days.
Four steps. No surprises.
Intro call
20 minutes. We confirm fit, you confirm you can share transcripts.
You send transcripts
Any format. We handle the rest.
Review and report
We run the analysis and deliver the report. Turnaround depends on dataset size — we give you a specific date after Step 01.
Debrief
60 minutes with the founder. We walk through findings. You ask anything.
Founded by Michal Lipka — PhD, 10+ years in biotech commercial roles, formally trained in Miller Heiman, Sandler, and other sales methodologies — and Andrej Kaurin (CTO).
Backed by mentors with 25+ years of life sciences commercial leadership.
Apply for a pilot.
Seven questions. Two minutes. We reply within 48 hours.